Prenatal Exposure Effects Psychophysiology Study
PEEPS
Prenatal Cocaine and Neurobehavioral Factors Underlying Mother-Infant Interaction
1 other identifier
observational
150
1 country
1
Brief Summary
The purpose of the study is to understand the biology and behavior of early mother-infant attachment, and to investigate how it may be affected by prenatal substance exposures. The investigators are interested in how drugs such as cocaine, alcohol, marijuana and cigarette smoking affect both mother and baby.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jul 2008
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2008
CompletedFirst Submitted
Initial submission to the registry
May 28, 2010
CompletedFirst Posted
Study publicly available on registry
June 2, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
January 1, 2027
February 4, 2026
February 1, 2026
18.5 years
May 28, 2010
February 3, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Determine the effect of prenatal cocaine exposure on the neonatal brain. ventricular volumes
2 to 4 weeks of age
Study Arms (3)
Prenatal Cocaine
Use of cocaine at anytime during pregnancy. Subjects may also have used other drugs in combination with Cocaine
Prenatal Nicotine-Alcohol-Marijuana
Subjects may have used any of these drugs during pregnancy, alone or in combination. This group has not used cocaine during pregnancy.
Drug-Free Pregnancy
Subjects did not use any of the following drugs during pregnancy: cocaine, nicotine, alcohol, marijuana.
Eligibility Criteria
Pregnant women or mothers with their newborn infants.
You may qualify if:
- During pregnancy, mother has used any of the following:
- cocaine
- marijuana and/or alcohol but not cocaine
- nicotine (smoked cigarettes)
- no drugs during pregnancy
- Mother is pregnant or no more than 4 weeks postpartum
You may not qualify if:
- Mother has cardiovascular disease
- Delivery before 36 weeks or later than 42 weeks gestation
- Birth weight less than 5.5 lbs
- Baby was a multiple birth
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina, 27599, United States
Biospecimen
Plasma from mothers and buccal cells from infants will be stored for possible DNA analysis of target genes pending additional funding.
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Karen Grewen, PhD
University of North Carolina, Chapel Hill
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 28, 2010
First Posted
June 2, 2010
Study Start
July 1, 2008
Primary Completion (Estimated)
January 1, 2027
Study Completion (Estimated)
January 1, 2027
Last Updated
February 4, 2026
Record last verified: 2026-02
Data Sharing
- IPD Sharing
- Will not share